Mortality of patients with copd participating in chronic disease management programmes: A happy end?

I. Peytremann-Bridevaux, P. Taffe, B. Burnand, P. O. Bridevaux, M. A. Puhan

Research output: Contribution to journalArticlepeer-review

Abstract

Background Concerns about increased mortality could question the role of COPD chronic disease management (CDM) programmes. We aimed at extending a recent Cochrane review to assess the effects of CDM on mortality in patients with COPD. Methods Mortality data were available for 25 out of 29 trials identified in a COPD integrated care systematic review. Metaanalysis using random-effects models was performed, followed by subgroup analyses according to study length (3-12 months vs >12 months), main intervention component (exercise, self-management, structured followup) and use of an action plan. Results The meta-analysis showed no impact of CDM on mortality ( pooled OR: 1.00, 95% CI 0.79 to 1.28). Conclusions These results do not suggest that CDM programmes expose patients withCOPD to excessive mortality risk.

Original languageEnglish (US)
Pages (from-to)865-866
Number of pages2
JournalThorax
Volume69
Issue number9
DOIs
StatePublished - 2014
Externally publishedYes

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Fingerprint Dive into the research topics of 'Mortality of patients with copd participating in chronic disease management programmes: A happy end?'. Together they form a unique fingerprint.

Cite this